We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

COVID-19 Mathematical Model Indicates Flu Season May Cause 2.5-Fold Increase in Coronavirus Transmission

By HospiMedica International staff writers
Posted on 16 Sep 2020
Scientists using a mathematical model to study the first months of the corona pandemic in Europe have found that the decrease of COVID-19 cases in spring was also related to the end of the flu season and influenza may have increased transmission of the coronavirus by an average of 2.5-fold.

The results of the study by scientists at the Max Planck Institute for Infection Biology (Berlin, Germany) and the Institut Pasteur (Paris, France) suggest that the coming flu epidemic will have an amplifying impact on the COVID-19 pandemic. The researchers have emphasized the potential importance of flu vaccinations as a possible extra protection against COVID-19.

Illustration
Illustration

Data from earlier experiments led the team to investigate the effects of a co-infection with coronavirus and flu. The researchers developed a mathematical model of coronavirus transmission and mortality to decipher the influence of the flu season on the COVID-19 pandemic. The researchers modelled the course of the pandemic in Belgium, Norway, Italy and Spain. Four European countries in which the pandemic was differently pronounced during the first half of the year. To approach the real infection events, the model was based on known disease parameters like the "generation interval", i.e. the time needed for an infected person to infect another person. The researchers also took non-pharmaceutical countermeasures into account, since lockdowns and social distancing had an extensive impact on the pandemic. This was measured by the so-called Stringency Index, a value developed by Oxford University, which indicates the "strictness" of government anti-coronavirus measures.

After mathematically recreating the pandemic, the researchers were able to test various assumptions about the impact of the flu season. They checked if the model was more realistic under the assumption that influenza either reduces, increases, or does not influence the transmission rate of coronavirus. The team showed that influenza may have increased coronavirus transmission at the population level by 2–2.5 times, on average during the period of co-circulation. The researchers checked their model against data on daily deaths in the four countries, enabling them to demonstrate that their model is consistent with the observed pandemic mortality data. Without the amplifying impact of influenza, the model explained the observed data substantially less well - with significantly lower COVID-19 infection rates.

It remains open whether influenza patients are more likely to transmit coronavirus to others or whether flu makes people more susceptible to corona, although the latter seems more probable according to the researchers. Other research groups recently showed that flu viruses may increase susceptibility to COVID-19 in patients: Influenza viruses cause a higher production of the receptors that are used by the coronavirus to dock to human respiratory cells. These results imply that vaccinating against influenza may be essential in the coming flu season, not only to relieve hospitals, but also to contain the potential effect of influenza on the transmission of coronavirus.

Related Links:
Max Planck Institute for Infection Biology
Institut Pasteur



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Ultrasonic Cleaner
Cole-Parmer Ultrasonic Cleaner with Digital Timer
New
LED Examination Lamp
Clarity 50 LED

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles